Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.

Vuik FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, Dinis-Ribeiro M, Bento MJ, Zadnik V, Pellisé M, Esteban L, Kaminski MF, Suchanek S, Ngo O, Májek O, Leja M, Kuipers EJ, Spaander MC.

Gut. 2019 Oct;68(10):1820-1826. doi: 10.1136/gutjnl-2018-317592. Epub 2019 May 16.

2.

Real-world treatment patterns, resource use and cost burden of multiple myeloma in Portugal.

Antunes L, Rocha-Gonçalves F, Chacim S, Lefèvre C, Pereira M, Pereira S, Zagorska A, Bento MJ.

Eur J Cancer Care (Engl). 2019 Jul;28(4):e13026. doi: 10.1111/ecc.13026. Epub 2019 Mar 3.

PMID:
30828907
3.

The contribution of second primary cancers to the mortality of patients with a gastric first primary cancer.

Morais S, Antunes L, Bento MJ, Lunet N.

Eur J Gastroenterol Hepatol. 2019 Apr;31(4):471-477. doi: 10.1097/MEG.0000000000001348.

PMID:
30601339
4.

Risk and survival of third primary cancers in a population-based cohort of gastric cancer patients.

Morais S, Antunes L, Bento MJ, Lunet N.

Dig Liver Dis. 2019 Apr;51(4):584-588. doi: 10.1016/j.dld.2018.12.003. Epub 2018 Dec 12.

PMID:
30591366
5.

Second primary gastric cancers in a region with an overall high risk of gastric cancer.

Morais S, Antunes L, Bento MJ, Lunet N.

Gac Sanit. 2018 Dec 4. pii: S0213-9111(18)30235-8. doi: 10.1016/j.gaceta.2018.08.010. [Epub ahead of print]

6.

Survival probabilities and trends for lip, oral cavity and oropharynx cancers in Northern Portugal in the period 2000-2009.

Monteiro LS, Antunes L, Santos LL, Bento MJ, Warnakulasuriya S.

Ecancermedicalscience. 2018 Jul 31;12:855. doi: 10.3332/ecancer.2018.855. eCollection 2018.

7.

Second primary cancers and survival in patients with gastric cancer: association with prediagnosis lifestyles.

Morais S, Castro C, Antunes L, Peleteiro B, Bento MJ, Lunet N.

Eur J Cancer Prev. 2019 May;28(3):159-166. doi: 10.1097/CEJ.0000000000000447.

PMID:
29668653
8.

An explanatory and predictive model of the variation in esophageal cancer incidence on the basis of changes in the exposure to risk factors.

Castro C, Peleteiro B, Morais S, Severo M, Bento MJ, Lunet N.

Eur J Cancer Prev. 2018 May;27(3):213-220. doi: 10.1097/CEJ.0000000000000422.

PMID:
29324583
9.

Western long-term accuracy of serum pepsinogen-based gastric cancer screening.

Castro C, Dinis-Ribeiro M, Rodrigues ANG, Calheiros T, Santos J, Pereira P, Ramos M, Cunha H, Andrade M, Costa A, Sá L, Antunes L, Bento MJ, Lomba-Viana R.

Eur J Gastroenterol Hepatol. 2018 Mar;30(3):274-277. doi: 10.1097/MEG.0000000000001040.

PMID:
29215432
10.

Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.

Huang L, Jansen L, Balavarca Y, Molina-Montes E, Babaei M, van der Geest L, Lemmens V, Van Eycken L, De Schutter H, Johannesen TB, Fristrup CW, Mortensen MB, Primic-Žakelj M, Zadnik V, Becker N, Hackert T, Mägi M, Cassetti T, Sassatelli R, Grützmann R, Merkel S, Gonçalves AF, Bento MJ, Hegyi P, Lakatos G, Szentesi A, Moreau M, van de Velde T, Broeks A, Sant M, Minicozzi P, Mazzaferro V, Real FX, Carrato A, Molero X, Besselink MG, Malats N, Büchler MW, Schrotz-King P, Brenner H.

Gut. 2019 Jan;68(1):130-139. doi: 10.1136/gutjnl-2017-314828. Epub 2017 Nov 20.

PMID:
29158237
11.

Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes.

Babaei M, Jansen L, Balavarca Y, Sjövall A, Bos A, van de Velde T, Moreau M, Liberale G, Gonçalves AF, Bento MJ, Ulrich CM, Schrotz-King P, Lemmens V, Glimelius B, Brenner H.

Clin Colorectal Cancer. 2018 Mar;17(1):e129-e142. doi: 10.1016/j.clcc.2017.09.002. Epub 2017 Sep 28.

12.

Cumulative incidence estimates in the presence of competing risks.

Morais S, Antunes L, Bento MJ, Lunet N.

J Clin Epidemiol. 2018 Jun;98:153-154. doi: 10.1016/j.jclinepi.2017.09.011. Epub 2017 Sep 14. No abstract available.

PMID:
28919462
13.

Risk of second primary cancers among patients with a first primary gastric cancer: A population-based study in North Portugal.

Morais S, Antunes L, Bento MJ, Lunet N.

Cancer Epidemiol. 2017 Oct;50(Pt A):85-91. doi: 10.1016/j.canep.2017.08.007. Epub 2017 Aug 23.

PMID:
28843176
14.

Survival from cancer in the north region of Portugal: results from the first decade of the millennium.

Antunes L, Santos LL, Bento MJ.

Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S170-S175. doi: 10.1097/CEJ.0000000000000378.

PMID:
28590274
15.

MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.

Torres-Ferreira J, Ramalho-Carvalho J, Gomez A, Menezes FD, Freitas R, Oliveira J, Antunes L, Bento MJ, Esteller M, Henrique R, Jerónimo C.

Mol Cancer. 2017 Jan 31;16(1):26. doi: 10.1186/s12943-017-0604-0.

16.

Trends in gastric and esophageal cancer incidence in northern Portugal (1994-2009) by subsite and histology, and predictions for 2015.

Castro C, Peleteiro B, Bento MJ, Lunet N.

Tumori. 2017 Mar 24;103(2):155-163. doi: 10.5301/tj.5000542. Epub 2016 Aug 23.

PMID:
27647232
17.
18.

Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.

Pina F, Castro C, Ferro A, Bento MJ, Lunet N.

Eur J Cancer Prev. 2017 Sep;26(5):404-410. doi: 10.1097/CEJ.0000000000000285.

PMID:
27483413
19.

Minimally Invasive Colorectal Cancer Surgery in Europe: Implementation and Outcomes.

Babaei M, Balavarca Y, Jansen L, Gondos A, Lemmens V, Sjövall A, Brge Johannesen T, Moreau M, Gabriel L, Gonçalves AF, Bento MJ, van de Velde T, Kempfer LR, Becker N, Ulrich A, Ulrich CM, Schrotz-King P, Brenner H.

Medicine (Baltimore). 2016 May;95(22):e3812. doi: 10.1097/MD.0000000000003812. Erratum in: Medicine (Baltimore). 2016 Aug 26;95(34):e75d6.

20.

Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date.

Castro C, Antunes L, Lunet N, Bento MJ.

Eur J Cancer Prev. 2016 Sep;25(5):472-80. doi: 10.1097/CEJ.0000000000000199.

PMID:
26317384
21.

Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.

Bento MJ, Gonçalves G, Aguiar A, Castro C, Veloso V, Rodrigues V.

Cancer Epidemiol. 2015 Oct;39(5):783-9. doi: 10.1016/j.canep.2015.08.004. Epub 2015 Aug 24.

PMID:
26315486
22.

Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.

Maia S, Cardoso M, Pinto P, Pinheiro M, Santos C, Peixoto A, Bento MJ, Oliveira J, Henrique R, Jerónimo C, Teixeira MR.

PLoS One. 2015 Jul 15;10(7):e0132728. doi: 10.1371/journal.pone.0132728. eCollection 2015.

23.

Incidence of second primary cancers in North Portugal-a population-based study.

Pacheco-Figueiredo L, Antunes L, Bento MJ, Lunet N.

J Cancer Surviv. 2016 Feb;10(1):142-52. doi: 10.1007/s11764-015-0460-0. Epub 2015 Jul 10.

PMID:
26159159
24.

Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.

Arnold M, Holterhues C, Hollestein LM, Coebergh JW, Nijsten T, Pukkala E, Holleczek B, Tryggvadóttir L, Comber H, Bento MJ, Diba ChS, Micallef R, Primic-Žakelj M, Izarzugaza MI, Perucha J, Marcos-Gragera R, Galceran J, Ardanaz E, Schaffar R, Pring A, de Vries E.

J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1170-8. doi: 10.1111/jdv.12236. Epub 2013 Aug 21.

PMID:
23962170
25.

Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries.

Crocetti E, Caldarella A, Ferretti S, Ardanaz E, Arveux P, Bara S, Barrios E, Bento MJ, Bordoni A, Buzzoni C, Candela G, Colombani F, Delafosse P, Federico M, Francart J, Giacomin A, Grosclaude P, Guizard AV, Izarzugaza I, Konzelmann I, La Rosa F, Lapotre B, Leone N, Ligier K, Mangone L, Marcos-Gragera R, Martinez R, Michelena MJ, Michiara M, Miranda A, Molinié F, Mugarza-Gomez C, Paci E, Piffer S, Puig-Vives M, Sacchettini C, Sánchez MJ, Traina A, Tretarre B, Tumino R, Van Vaerenbergh E, Velten M, Woronoff AS.

Breast. 2013 Aug;22(4):476-81. doi: 10.1016/j.breast.2013.04.012. Epub 2013 May 10.

PMID:
23669022
26.

Evaluation of the frequency of and survival from second primary cancers in North Portugal: a population-based study.

Pacheco-Figueiredo L, Antunes L, Bento MJ, Lunet N.

Eur J Cancer Prev. 2013 Nov;22(6):599-606. doi: 10.1097/CEJ.0b013e32835f3bbc.

PMID:
23462457
27.

Mammographic screening programmes in Europe: organization, coverage and participation.

Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, Hofvind S, Nyström L, Segnan N, Ponti A; Eunice Working Group, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:72-82.

PMID:
22972813
28.

False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.

Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S; EUNICE Project and Euroscreen Working Groups, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:57-66. Review.

PMID:
22972811
29.

Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal.

Monteiro LS, Antunes L, Bento MJ, Warnakulasuriya S.

J Oral Pathol Med. 2013 Apr;42(4):345-51. doi: 10.1111/jop.12010. Epub 2012 Oct 4.

PMID:
23034073
30.

Cancer incidence and survival (1997-2006) among adolescents and young adults in the north of Portugal.

Carreira H, Antunes L, Castro C, Lunet N, Bento MJ.

Pediatr Hematol Oncol. 2012 Oct;29(7):663-76. Epub 2012 Sep 11.

PMID:
22966906
31.

Prediagnosis lifestyle exposures and survival of gastric cancer patients: a cohort study from Portugal.

Ferronha I, Castro C, Carreira H, Bento MJ, Carvalho I, Peleteiro B, Lunet N.

Br J Cancer. 2012 Jul 24;107(3):537-43. doi: 10.1038/bjc.2012.258. Epub 2012 Jun 14.

32.

Assessing the completeness of cancer registration using suboptimal death certificate information.

Castro C, Bento MJ, Lunet N, Campos P.

Eur J Cancer Prev. 2012 Sep;21(5):478-9. doi: 10.1097/CEJ.0b013e32834f811c. No abstract available.

PMID:
22193365
33.

Serum pepsinogen test for early detection of gastric cancer in a European country.

Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, Vieira AS, Bento MJ, Lomba-Viana H.

Eur J Gastroenterol Hepatol. 2012 Jan;24(1):37-41. doi: 10.1097/MEG.0b013e32834d0a0a.

PMID:
21989121
34.

Health-related behaviours in the EpiPorto study: cancer survivors versus participants with no cancer history.

Pacheco-Figueiredo L, Antunes L, Bento MJ, Lunet N.

Eur J Cancer Prev. 2011 Jul;20(4):348-54. doi: 10.1097/CEJ.0b013e328345f923.

PMID:
21487296
35.

Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis.

Seixas F, Palmeira C, Pires MA, Bento MJ, Lopes C.

Vet J. 2011 Jan;187(1):65-71. doi: 10.1016/j.tvjl.2009.10.030. Epub 2009 Dec 1.

PMID:
19955006
36.

DNA content in malignant salivary gland tumours.

Monteiro LS, Palmeira C, Bento MJ, Lopes C.

Oral Dis. 2009 May;15(4):295-301. doi: 10.1111/j.1601-0825.2009.01525.x. Epub 2009 Mar 23.

PMID:
19320959
37.

Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.

Monteiro LS, Bento MJ, Palmeira C, Lopes C.

J Oral Pathol Med. 2009 Jul;38(6):508-13. doi: 10.1111/j.1600-0714.2009.00770.x. Epub 2009 Mar 20.

PMID:
19317849
38.

Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients.

Barros-Silva JD, Leitão D, Afonso L, Vieira J, Dinis-Ribeiro M, Fragoso M, Bento MJ, Santos L, Ferreira P, Rêgo S, Brandão C, Carneiro F, Lopes C, Schmitt F, Teixeira MR.

Br J Cancer. 2009 Feb 10;100(3):487-93. doi: 10.1038/sj.bjc.6604885. Epub 2009 Jan 20.

39.

Validation of a consciousness level scale for palliative care.

Gonçalves F, Bento MJ, Alvarenga M, Costa I, Costa L.

Palliat Med. 2008 Sep;22(6):724-9. doi: 10.1177/0269216308094104.

PMID:
18715971
40.

Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities.

Bovee TF, Schoonen WG, Hamers AR, Bento MJ, Peijnenburg AA.

Anal Bioanal Chem. 2008 Feb;390(4):1111-9. doi: 10.1007/s00216-007-1772-3. Epub 2008 Jan 11.

PMID:
18188547
41.

BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families.

Peixoto A, Salgueiro N, Santos C, Varzim G, Rocha P, Soares MJ, Pereira D, Rodrigues H, Bento MJ, Fráguas A, Moura G, Regateiro F, Castedo S, Teixeira MR.

Fam Cancer. 2006;5(4):379-87. Epub 2006 Jul 7.

PMID:
16826315
42.

Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours.

Santos L, Costa C, Pereira S, Koch M, Amaro T, Cardoso F, Guimarães T, Bento MJ, Lobo F, Pinto S, Lopes C.

Ann Oncol. 2003 Sep;14(9):1419-24.

PMID:
12954582
43.

Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification.

Santos L, Amaro T, Costa C, Pereira S, Bento MJ, Lopes P, Oliveira J, Criado B, Lopes C.

Int J Cancer. 2003 Jun 10;105(2):267-72.

44.

Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.

Santos LL, Amaro T, Pereira SA, Lameiras CR, Lopes P, Bento MJ, Oliveira J, Criado B, Lopes CS.

Eur J Surg Oncol. 2003 Feb;29(1):74-80.

PMID:
12559081
45.

I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.

Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D.

Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):445-50.

46.

Use of cell block preparation for morphological, immunocytochemistry, and ploidy analysis in ThinPrep monolayer preparations.

Freitas C, Milanezi F, Dias AJ, Bento MJ, Schmitt FC.

Diagn Cytopathol. 2001 Dec;25(6):415-7. No abstract available.

PMID:
11747241
47.

Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.

Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, Lopes P, Olson S, Silva MD, Page DL.

Hum Pathol. 2001 May;32(5):487-93.

PMID:
11381366
48.

Captopril effects on the rat adrenal cortex.

Pignatelli D, Maia M, Bento MJ, Sousa S, Azevedo ME, Magalhães MM, Magalhães MC, Vinson GP.

Endocr Res. 2000 Nov;26(4):965-72. No abstract available.

PMID:
11196477
49.

Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma.

Henrique R, Azevedo R, Bento MJ, Domingues JC, Silva C, Jerónimo C.

J Am Acad Dermatol. 2000 Dec;43(6):991-1000.

PMID:
11100014
50.

[Diagnosis of paradoxal and concomitant pulmonary thromboembolism with transesophageal echocardiography: a clinical case].

Abreu A, Branco L, Bento MJ, Patrício L, Rasteiro R, Bico P, Salomão S, Antunes AM.

Rev Port Cardiol. 2000 Jul-Aug;19(7-8):823-8. Portuguese.

PMID:
11014085

Supplemental Content

Loading ...
Support Center